Interleukin-4 (IL-4) enhances and soluble interleukin-4 receptor (sIL- 4R) inhibits histamine release from peripheral blood basophils and mast cells in vitro and in vivo

Mediators of Inflammation

Volumn 6, Issue 2, 1997, Pages 111-118

  Niggemann, B ^a   Zuberbier, T ^a   Herz, U ^a   Enssle, K ^b   Wahn, U ^a   Renz, H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Behringwerke AG   (Germany)

Author keywords

Allergy; Basophil; Histamine release; IL 4; Mast cell; Mice; sIL 4R

Indexed keywords

ALLERGEN; HISTAMINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; OVALBUMIN; POLLEN ANTIGEN;

ADULT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; ATOPIC DERMATITIS; ATOPY; BASOPHIL; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SKIN ALLERGY; T LYMPHOCYTE;

ANIMALIA; MURINAE;

EID: 0030940247     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359791802     Document Type: Article

References (33)

1. Ricci M. IL-4: a key cytokine in atopy. Clin Exp Allergy 1994; 24: 801-812.
2. Del Prete G, Maggi E, Parronchi P, Chrétien I, Tiri A, Macchia D, Ricci M, Banchereau J, De Vries J, Romanani S. IL-4 is an essential factor for the synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140: 4193-4198.
3. Jabara HH, Ahern DJ, Vercelli D, Geha RS. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J Immunol 1991; 147: 1557-1560.
4. Lebman DA, Coffman RL. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J Exp Med 1988; 188: 853-862.
5. Finkelman FD, Katona IM, Urban JF Jr, Holmes J, Ohara J, Tung AS, Sample JvG, Paul WE. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988; 141: 2335-2341.
6. Galéa P, Thibault G, Lacord M, Bardos P, Lebranchu Y. IL-4, but not tumor necrosis factor-α, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway. J Immunol 1993; 151: 588-596.
7. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luskinskas FW, Gimbrone MA Jr, McIntire BW, Bochner BS. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol 1992; 148: 1086-1092.
8. Dubois GR, Bruijnzeel-Koomen CAFM, Bruijnzeel PLB. IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals. J Invest Dermatol 1994; 102: 843-846.
9. Valent P, Bevec D, Maurer D, Besemer J, Di Padova F, Butterfield JH, Speiser W, Majdic O, Lechner K, Bettelheim P. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci 1991; 88: 3339-3342.
10. Jujo K, Renz H, Abe J, Gelfand EW, Leung DYM. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992; 90: 323-331.
11. Gagnon R, Lian J, Boutin Y, Hébert J. Seasonal enhancement of IL-4 induced IgE synthesis by peripheral blood mononuclear cells of atopic patients. Clin Exp Allergy 1993; 23: 498-503.
12. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST. Interleukin 4 is localized to and released from human mast cells. J Exp Med 1992; 176: 1381-1386.
13. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993; 177: 605-611.
14. Schroeder JT, MacGlashan DW, Kagey-Sobotka A, White JM, Lichtenstein LM. IgE-dependent IL-4 secretion by human basophils. J Immunol 1994; 153: 1808-1817.
15. Valent P, Besemer J, Kishi K, Di Padova F, Geissler K, Lechner K, Bettelheim P. Human basophils express interleukin-4 receptors. Blood 1990; 76: 1734-1738.
16. Maliszewski CR, Sato TA, van den Bos T, Waugh S, Dower SK, Slack J, Beckmann MP, Grabstein KH. Recombinant soluble receptors specifically inhibit IL-1 and IL-4 induced B cell activities in vitro. J Immunol 1990; 144: 3028-3033.
17. Garrone P, Djossou O, Galizzi JP, Bancherau J. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur J Immunol 1991; 21: 1365-1369.
18. Renz H, Enssle K, Lauffer L, Kurrle R, Gelfand EW. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor. Int Arch Allergy Immunol 1995; 106: 46-54.
19. Idzerda RL, March CJ, Mosley B, Lyman SD, Van den Bos T, Gimpel SD, Din WS, Grabstein KH, Widmer MD, Park LS, et al. Human interleukin-4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990; 171: 861-873.
20. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, Van den Bos T, Friend D, Alpert A, Anderson D, Jackson J, Wignall JM, Smith C, Gallis B, Sims JE, Urdal D, Widmer MB, Cosman D, Park LS. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 1989; 59: 335-348.
21. Wahn U, Ernsting M, Peterson J. Spontaneous histamine release from washed leucocytes and whole blood in atopic and non-atopic individuals. Allergy 1990; 45: 109-114.
22. Lowman MA, Rees PH, Benyon RC, Church ML. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 1988; 81: 590-597.
23. Siraganian RP. Refinements in the automated fluorometric histamine analysis system. J Immunol Meth 1975; 7: 283-290.
24. Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsivesness in the mouse. J Allergy Clin Immunol 1992; 89: 1127-1138.
25. Saloga J, Renz H, Lack G, Bradley KL, Greenstein JL, Larsen G, Gelfand EW. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen. J Clin Invest 1993; 91: 133-140.
26. Tang M, Kemp A, Varigos G. IL-4 and interferon-gamma production in children with atopic disease. Clin Exp Immunol 1993; 92: 120-124.
27. Larsen GL, Renz H, Loader JE, Bradley KL, Gelfand EW. Airway response to electrical field stimulation in sensitized inbred mice. J Clin Invest 1992; 89: 747-752.
28. Aoki I, Kinzer C, Shirai A, Paul WE, Klinman DM. IgE receptor positive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice. Proc Natl Acad Sci USA 1995; 92: 2534-2538.
29. Schroeder JT, MacGlashan DW, Kagey-Sobotka A, White JM, Lichtenstein LM. Ige-dependent IL-4 secretion by human basophils. J Immunol 1994; 153: 1808-1817.
30. Casolaro V, Spadaro G, Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990; 142: 1108-1111.
31. Lichey J, Zuberbier T, Luck W, Lau S, Wahn U. Influence of glycosphingolipids on the release of histamine and sulfidopeptide leukotrienes from human basophils. Int Arch Allergy Immunol 1994; 103: 252-259.
32. Renz H, Bradley K, Enssle KH, Loader JE, Larsen GL, Gelfand EW. Prevention of the development of immediate hypersensitivity and airway responsiveness following in vivo treatment with soluble IL-4 receptor. Int Arch Allergy Immunol 1996; 109: 167-176.
33. Lack G, Renz H, Saloga J, Bradley KL, Loader J, Leung DYM, Larsen G, Gelfand EW. Nebulized but not parenteral IFN-γ decreases IgE production and normalizes airway function in a murine model of allergen sensitisation. J Immunol 1994; 152: 2546-2554.